Jürgen Finke
- Hematology top 0.05%
- Hematopoietic Stem Cell Transplantation 203
- Acute Myeloid Leukemia Research 125
- Chronic Myeloid Leukemia Treatments 48
- Genetics top 0.1%
- Chronic Lymphocytic Leukemia Research 33
- Immunology top 0.5%
- Immune Cell Function and Interaction 52
- T-cell and B-cell Immunology 26
- Transplantation top 1%
- Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment 59
-
- Acute Lymphoblastic Leukemia research 84
Jürgen Finke
375 papers receiving 12.7k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Hematology 6.9k
- Genetics 2.7k
- Immunology 3.4k
- Transplantation 389
- Pathology and Forensic Medicine 2.6k
Countries citing papers authored by Jürgen Finke
This map shows the geographic impact of Jürgen Finke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jürgen Finke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jürgen Finke more than expected).
Fields of papers citing papers by Jürgen Finke
This network shows the impact of papers produced by Jürgen Finke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jürgen Finke. The network helps show where Jürgen Finke may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jürgen Finke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 2 | |
| 9 | 2021 | 8 | |
| 10 | 2019 | 15 | |
| 11 | 2015 | 84 | |
| 12 | 2012 | 45 | |
| 13 | 2012 | 67 | |
| 14 | HUMAN LEUKOCYTE ANTIGEN MATCHING AND CONDITIONING IMPACT ON LONG-TERM TRANSPLANT OUTCOME AFTER ALLOGENEIC HSCT FOR CHRONIC LYMPHOCYTIC LEUKEMIA | 2010 | 1 |
| 15 | 2007 | 360 | |
| 16 | 2004 | 3 | |
| 17 | Allogeneic stem cell transplantation with matched related and unrelated donors for patients with refractory anemia: T-cell depletion and reduced intensity regimens are associated with increased relapse risk | 2003 | 1 |
| 18 | Konfliktzentrierte Monotherapie oder Methodenintegration? Veränderungsprozesse von Gesprächspsychotherapie mit und ohne verhaltenstherapeutische Reizkonfrontation bei Agoraphobie mit Panikstörung | 2001 | 2 |
| 19 | The importance of patient selection in nonmyeloablative stem cell transplant (NMSCT) for acute and chronic leukaemia, myelodysplastic syndrome, and myeloma | 2000 | 2 |
| 20 | 1999 | 6 |
About Jürgen Finke
Jürgen Finke is a scholar working on Hematology, Genetics and Transplantation, having authored 396 papers that have together received 12.9k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (203 papers), Acute Myeloid Leukemia Research (125 papers), Acute Lymphoblastic Leukemia research (84 papers), Lymphoma Diagnosis and Treatment (59 papers), Immune Cell Function and Interaction (52 papers), Chronic Myeloid Leukemia Treatments (48 papers), Chronic Lymphocytic Leukemia Research (33 papers) and T-cell and B-cell Immunology (26 papers). The work is most often cited by research in Hematology (6.9k citations), Genetics (2.7k citations) and Immunology (3.4k citations). Jürgen Finke has collaborated with scholars based in Germany, France and Israel. Frequent co-authors include Hartmut Bertz, Roland Mertelsmann, Myriam Labopin, Robert Zeiser, Vanderson Rocha, Gabriele Ihorst, Ralph Wäsch, W. Lange, Rainer Schwerdtfeger and Gottfried Dölken. Their work appears in journals such as New England Journal of Medicine, Nature Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.